SELECT PUBLICATIONS

Goss PE. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial. Semin Oncol 2006 33(2 Suppl 7):8-12. Abstract

Goss PE et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17. J Natl Cancer Inst 2005;97(17):1262-71. Abstract

Ingle JN et al. Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Breast Cancer Res Treat 2006;99(3):295-300. Abstract

Robert NJ et al. Updated analysis of NCIC CTG MA.17 (letrozole vs placebo to letrozole vs placebo) post unblinding. Proc ASCO 2006;Abstract 550.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table of Contents

Top of Page

Home · Search

Editor:
Neil Love, MD

Interviews

Melvin J Silverstein, MD
- Select publications

David M Hyams, MD
- Select publications

Charles E Geyer Jr, MD
- Select publications

Hope S Rugo, MD
- Select publications

Highlights of a CME Symposium Held in Conjunction with The American Society of Breast Surgeons Eighth Annual Meeting
- Select publications

A CME Audio Series and Activity

Faculty Disclosures

Editor's Office